New York Genome Center
About the Company
The New York Genome Center (NYGC) is an independent, nonprofit academic research institution focused on furthering genomic research that leads to scientific advances and new insights and therapies for patients with neurodegenerative disease, neuropsychiatric disease, and cancer.
Leveraging our strengths in whole genome sequencing, genomic analysis, and development of genomic tools, the NYGC serves as a nexus for collaboration in genomic research for the New York community and beyond.
The New York Genome Center (NYGC) strives to create a workplace environment that is welcoming and fair to all regardless of race, ethnicity, gender, sexual orientation, physical ability, age, or religion. We are committed to diversity, equity, and inclusion in all that we do. We believe that when people of various backgrounds, life experiences, and perspectives work together in an inclusive and equitable environment, we all gain new and valuable perspectives that otherwise would have been missed. Valuing and supporting each NYGC employee as an individual while helping each realize their full potential is critical to promoting greater collaboration, innovation, and discovery.
In response to recent events that have highlighted systemic racism and inequalities in our society, NYGC established its Diversity, Equity & Inclusion Advisory Group (DE&I AG) to put the principles outlined above into practice through a number of action items that we are considering. Some initial prospects include providing appropriate unconscious bias training and resources to employees; developing mentorship opportunities and internship programs for underrepresented minorities; evaluating our hiring process and measuring overall engagement; and broadening and encouraging diversity, equity, and inclusion at NYGC events.
We recognize that there is still work to be done that will require sustained commitment from the entire organization, and we embrace the opportunity.